drugset / Trial / NCT02412657

Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block

NCT02412657 ↗

Completed 75 enrolled Maisonneuve-Rosemont Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Interscalene brachial plexus block provides excellent but time limited analgesia. Intravenous dexamethasone increases the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder arthroscopic surgery. We want to evaluate the effect of two different doses (dexamethasone 10 mg i.v. vs 4 mg i.v. vs placebo) on the analgesic duration of a single-shot inter scalene block. Our study hypothesis is that dexamethasone 4 mg i.v. is equivalent to dexamethasone10 mg i.v. in prolonging the analgesic duration of a single-shot interscalene block with ropivacaine.

Timeline

Start
2014-09
Primary completion
2015-10
Completion
2015-11

Outcome

Met primary endpoint

paper This difference was statistically significant for D4 and D10 compared with placebo PMID 28050801 ↗

paper D4 and D10 compared with placebo (median difference [MD], 7.8 hr; 95% confidence interval [CI], 4.6 to 11.1 hr; P < 0.001 PMID 28050801 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Intravenous
Subject Dexamethasone Small molecule 10 mg Intravenous

Indications

No indication recorded.